Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NeuroMetrix (NURO)

NeuroMetrix Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NURO
DateTimeSourceHeadlineSymbolCompany
19/12/202415:24Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:NURONeuroMetrix Inc
18/12/202414:03PR Newswire (US)Kuehn Law Encourages PWOD, NURO, BHLB, and BRKL Investors to Contact Law FirmNASDAQ:NURONeuroMetrix Inc
17/12/202422:27Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:NURONeuroMetrix Inc
17/12/202422:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NURONeuroMetrix Inc
17/12/202421:05GlobeNewswire Inc.NeuroMetrix to be Acquired by electroCoreNASDAQ:NURONeuroMetrix Inc
05/11/202421:23Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NURONeuroMetrix Inc
05/11/202415:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
05/11/202412:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NURONeuroMetrix Inc
05/11/202412:00GlobeNewswire Inc.NeuroMetrix Reports Q3 2024 Business HighlightsNASDAQ:NURONeuroMetrix Inc
02/10/202420:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
27/09/202419:56Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:NURONeuroMetrix Inc
26/09/202421:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
26/09/202420:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
13/08/202418:47GlobeNewswire Inc.NeuroMetrix Reiterates its Review of Strategic AlternativesNASDAQ:NURONeuroMetrix Inc
06/08/202420:24Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NURONeuroMetrix Inc
06/08/202411:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NURONeuroMetrix Inc
06/08/202411:00GlobeNewswire Inc.NeuroMetrix Reports Q2 2024 Business Highlights and Update on Review of Strategic OptionsNASDAQ:NURONeuroMetrix Inc
31/07/202418:03GlobeNewswire Inc.NeuroMetrix, Inc. Announces Date for Second Quarter 2024 Business Highlights Conference CallNASDAQ:NURONeuroMetrix Inc
31/05/202417:15Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:NURONeuroMetrix Inc
24/05/202421:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
24/05/202421:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
24/05/202421:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
15/05/202420:00GlobeNewswire Inc.NeuroMetrix Reports Q1 2024 Business HighlightsNASDAQ:NURONeuroMetrix Inc
15/05/202416:33Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NURONeuroMetrix Inc
15/05/202415:19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NURONeuroMetrix Inc
07/05/202420:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
19/04/202412:00GlobeNewswire Inc.NeuroMetrix Announces Steps Taken to Enhance Shareholder ValueNASDAQ:NURONeuroMetrix Inc
14/03/202413:00GlobeNewswire Inc.NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral NeuropathyNASDAQ:NURONeuroMetrix Inc
13/03/202413:00GlobeNewswire Inc.NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® FibromyalgiaNASDAQ:NURONeuroMetrix Inc
06/03/202422:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
 Showing the most relevant articles for your search:NASDAQ:NURO